Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Goldman Eye is a premier ophthalmology practice and clinical research center located in Palm Beach Gardens, Florida. Founded and led by Dr. David Goldman, the facility specializes in providing advanced surgical and medical eye care while serving as a high-volume site for ophthalmic clinical trials. The organization partners with leading global pharmaceutical and medical device companies to conduct Phase I-IV studies across various indications, including cataracts, dry eye, and refractive surgery. As a key contributor to ophthalmic innovation, Goldman Eye provides the clinical infrastructure necessary for the validation of new drugs and surgical technologies. The center is recognized for its expertise in anterior segment procedures and its role in bringing novel ophthalmic therapies to market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Goldman Eye.